REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 69 filers reported holding REGENXBIO INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $898,000 | -75.6% | 48,400 | -81.6% | 0.05% | -62.3% |
Q3 2016 | $3,687,000 | +11.9% | 263,177 | -36.1% | 0.14% | -19.8% |
Q2 2016 | $3,295,000 | +1.6% | 411,926 | +37.2% | 0.17% | +6.2% |
Q1 2016 | $3,244,000 | +67.2% | 300,329 | +157.0% | 0.16% | +51.4% |
Q4 2015 | $1,940,000 | – | 116,860 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 839,139 | $35,177,000 | 6.39% |
Sonic Fund II, L.P. | 188,786 | $7,914,000 | 4.47% |
ArchPoint Investors | 297,355 | $12,465,000 | 3.73% |
Redmile Group, LLC | 2,008,001 | $84,175,000 | 1.47% |
RTW INVESTMENTS, LP | 1,845,366 | $77,358,000 | 1.17% |
WS MANAGEMENT LLLP | 210,729 | $8,834,000 | 0.94% |
FRAZIER MANAGEMENT LLC | 235,809 | $9,885,000 | 0.79% |
Integral Health Asset Management, LLC | 55,000 | $2,306,000 | 0.66% |
Sofinnova Investments, Inc. | 127,593 | $5,349,000 | 0.32% |
HHLR ADVISORS, LTD. | 456,000 | $19,116,000 | 0.25% |